Skip to main content
Equibles

Jefferies Financial Group Inc.

Position in GPCR — Structure Therapeutics Inc.

CIK 96223 NEW YORK, NY
Back to GPCR Full portfolio

Position in GPCR

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$2,180,343
-$836,591 QoQ
Shares Held
40,625
-35.1% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#86
of 190 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GPCR Over Time

Shares Held

Position Value (USD)

Derivatives in GPCR

reported options exposure · as of Dec 31, 2024
CallValue
$734,952
CallShares
27,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Jefferies Financial Group Inc. holds $677,219,224 across 66 Biotechnology names. GPCR ranks #34 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PTCT
Ptc Therapeutics, Inc.
 1,357,042 $110,693,915
2 URGN
UroGen Pharma Ltd.
 2,199,652 $80,947,193
3 IMTX
Immatics N.V.
 6,506,802 $65,913,904
4 TNGX
Tango Therapeutics, Inc.
 2,010,534 $62,849,292
5 CGON
CG Oncology, Inc.
 769,947 $54,704,734
6 ARGX
Argenx SE
 45,068 $41,812,738
7 RARE
Ultragenyx Pharmaceutical Inc.
 929,626 $31,040,212
8 BMRN
Biomarin Pharmaceutical Inc
 466,258 $26,679,282

All Filings in GPCR

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,180,343 40,625
2026-03-31 $3,016,934 62,592
2025-12-31 $7,163,163 102,993
2025-09-30 $4,769,660 170,345
2024-12-31 $734,952 27,100
2024-12-31 $54,240 2,000
2024-09-30 $307,230 7,000
2024-09-30 $1,189,419 27,100
2024-03-31 $85,720 2,000
2024-03-31 $2,010,134 46,900